Fariba Behbod

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
    Fariba Behbod
    Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    Breast Cancer Res 11:R66. 2009
  2. ncbi Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential
    Frances S Kittrell
    Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Breast Cancer Res 13:R41. 2011
  3. ncbi Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
    Kelli Elizabeth Valdez
    Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    J Pathol 225:565-73. 2011
  4. ncbi Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer
    Hanan S Elsarraj
    Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Mammary Gland Biol Neoplasia 17:79-87. 2012
  5. ncbi Overactivation of Ras signaling pathway in CD133+ MPNST cells
    Emma Borrego-Diaz
    KUMC Molecular Medicine Laboratory, Department of Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Neurooncol 108:423-34. 2012
  6. ncbi BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation
    Shane R Stecklein
    Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Proc Natl Acad Sci U S A 109:13650-5. 2012
  7. ncbi Targeting the perpetrator: breast cancer stem cell therapeutics
    Arindam Pal
    The University of Kansas Medical Center, 3901 Rainbow Blvd, Lied G015, Kansas City, KS, 66160, USA
    Curr Drug Targets 11:1147-56. 2010

Collaborators

  • Daniel Medina
  • D Craig Allred
  • Hanan S Elsarraj
  • David Edwards
  • Heather L LaMarca
  • Fang Fan
  • K Polyak
  • Shane R Stecklein
  • Emma Borrego-Diaz
  • Kelli Elizabeth Valdez
  • Frances S Kittrell
  • Martha Z Carletti
  • Arindam Pal
  • Wenjia Wang
  • Meena Upadhyaya
  • Melanie Spyra
  • Roy A Jensen
  • Easwari Kumaraswamy
  • Faris Farassati
  • Victor F Mautner
  • Tuba Esfandyari
  • Sarah Taylor
  • Kaoru Terai
  • Lisa M Harlan-Williams
  • Luis F Parada
  • Kristina Lialyte
  • Vamsee Chaguturu
  • Amanda L Wise
  • Wa Xian
  • Mei Zhang
  • William Smith
  • Sofia Kerbawy
  • Jeffrey M Rosen
  • Arnoud Sonnenberg
  • Jessica Heestand
  • Kelli E Valdez

Detail Information

Publications7

  1. ncbi An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
    Fariba Behbod
    Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    Breast Cancer Res 11:R66. 2009
    ..The resulting models, which mimicked some of the diversity of human noninvasive breast cancers in vivo, were used to show whether subtypes of human DCIS might contain distinct subpopulations of tumor-initiating cells...
  2. ncbi Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential
    Frances S Kittrell
    Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Breast Cancer Res 13:R41. 2011
    ....
  3. ncbi Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
    Kelli Elizabeth Valdez
    Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    J Pathol 225:565-73. 2011
    ....
  4. ncbi Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer
    Hanan S Elsarraj
    Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Mammary Gland Biol Neoplasia 17:79-87. 2012
    ..Despite the numerous reports concerning miR-146a/b in human cancers, the mechanistic contributions of these miRNAs in both normal and neoplastic mammary gland development and biology remains poorly characterized...
  5. ncbi Overactivation of Ras signaling pathway in CD133+ MPNST cells
    Emma Borrego-Diaz
    KUMC Molecular Medicine Laboratory, Department of Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Neurooncol 108:423-34. 2012
    ..The wild population was more sensitive to inhibition of proliferation by this inhibitor as compared with the CD133+ cells supporting previous studies observing enhanced chemoresistance of these cells...
  6. ncbi BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation
    Shane R Stecklein
    Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Proc Natl Acad Sci U S A 109:13650-5. 2012
    ....
  7. ncbi Targeting the perpetrator: breast cancer stem cell therapeutics
    Arindam Pal
    The University of Kansas Medical Center, 3901 Rainbow Blvd, Lied G015, Kansas City, KS, 66160, USA
    Curr Drug Targets 11:1147-56. 2010
    ..As a result, knowledge of biological pathways that govern CSCs is very important and this review is focused on the biology of CSCs with special emphasis on breast CSCs, and recent advances in therapeutic approaches targeting them...